{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:47:51Z","timestamp":1771012071325,"version":"3.50.1"},"reference-count":144,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tcmonline.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.tcm.2016.02.007","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T14:49:20Z","timestamp":1457016560000},"page":"495-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Endovascular treatment of lower extremity peripheral arterial disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Andrew J.","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles B.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2016.02.007_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2016.02.007_bib2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/CIRCOUTCOMES.109.930735","article-title":"Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States","volume":"3","author":"Mahoney","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.tcm.2016.02.007_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999\u20132004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.02.007_bib4","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/01.CIR.82.6.1925","article-title":"Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study","volume":"82","author":"Smith","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.02.007_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Ankle Brachial Index","year":"2008","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2016.02.007_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1358863X07084911","article-title":"The impact of peripheral arterial disease on health-related quality of life in the peripheral arterial disease awareness, risk, and treatment: New Resources for Survival (PARTNERS) Program","volume":"13","author":"Regensteiner","year":"2008","journal-title":"Vasc Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jacc.2007.05.030","article-title":"Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease","volume":"50","author":"McDermott","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.292.4.453","article-title":"Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms","volume":"292","author":"McDermott","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2016.02.007_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1067\/mva.2002.125747","article-title":"Nottingham Health Profile and Short-Form 36 health survey questionnaires in patients with chronic lower limb ischemia: before and after revascularization","volume":"36","author":"Klevsgard","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1148\/radiol.2501080607","article-title":"Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training\u2014randomized controlled trial","volume":"250","author":"Spronk","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.tcm.2016.02.007_bib11","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMra021135","article-title":"Exercise training for claudication","volume":"347","author":"Stewart","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib12","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.2015.14851","article-title":"Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial","volume":"314","author":"Fakhry","year":"2015","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2016.02.007_bib13","doi-asserted-by":"crossref","first-page":"e000711","DOI":"10.1161\/JAHA.113.000711","article-title":"Home-based walking exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial","volume":"3","author":"McDermott","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2016.02.007_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2013.7231","article-title":"Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial","volume":"310","author":"McDermott","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2016.02.007_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1358863X10361545","article-title":"A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication","volume":"15","author":"Pande","year":"2010","journal-title":"Vasc Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib16","doi-asserted-by":"crossref","first-page":"W314","DOI":"10.2214\/AJR.10.6132","article-title":"Utilization of lower extremity arterial disease diagnostic and revascularization procedures in Medicare beneficiaries 2000-2007","volume":"197","author":"Harris","year":"2011","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.tcm.2016.02.007_bib17","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1056\/NEJMoa041905","article-title":"Coronary-artery revascularization before elective major vascular surgery","volume":"351","author":"McFalls","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0967-2109(98)00115-X","article-title":"Screening for asymptomatic carotid stenosis in patients with peripheral vascular disease: a prospective study and risk factor analysis","volume":"7","author":"Cheng","year":"1999","journal-title":"Cardiovasc Surg"},{"issue":"Suppl. S","key":"10.1016\/j.tcm.2016.02.007_bib19","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib20","first-page":"501","volume":"79","author":"Rooke","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib21","doi-asserted-by":"crossref","first-page":"e000697","DOI":"10.1161\/JAHA.113.000697","article-title":"Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease","volume":"3","author":"Armstrong","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2016.02.007_bib22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","article-title":"Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia","volume":"63","author":"Westin","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib23","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2016.02.007_bib24","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.286.13.1599","article-title":"Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment","volume":"286","author":"McDermott","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2016.02.007_bib25","first-page":"591","article-title":"The natural course of arteriosclerosis of the lower extremities","volume":"55","author":"Boyd","year":"1962","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib26","first-page":"795","article-title":"Intermittent claudication: its natural course","volume":"78","author":"Imparato","year":"1975","journal-title":"Surgery"},{"key":"10.1016\/j.tcm.2016.02.007_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-9610(76)90351-2","article-title":"The fate of patients with intermittent claudication managed nonoperatively","volume":"132","author":"McAllister","year":"1976","journal-title":"Am J Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1358863X07079823","article-title":"Current state of endovascular treatment of femoro-popliteal artery disease","volume":"12","author":"Zeller","year":"2007","journal-title":"Vasc Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib29","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ccd.22124","article-title":"Quantitative assessment of the conformational change in the femoropopliteal artery with leg movement","volume":"74","author":"Klein","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ccd.22802","article-title":"Percutaneous revascularization of long femoral artery lesions for claudication: patency over 2.5 years and impact of systematic surveillance","volume":"77","author":"Connors","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ccd.25395","article-title":"SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use","volume":"84","author":"Gray","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ccd.25505","article-title":"SCAI expert consensus statement for aorto-iliac arterial intervention appropriate use","volume":"84","author":"Klein","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ccd.25504","article-title":"SCAI expert consensus statement for femoral-popliteal arterial intervention appropriate use","volume":"84","author":"Klein","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1078-5884(96)80044-X","article-title":"Outcome of unreconstructed chronic critical leg ischaemia","volume":"11","author":"Lepantalo","year":"1996","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1078-5884(97)80067-6","article-title":"Critical and subcritical ischaemia","volume":"13","author":"Wolfe","year":"1997","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/ejvs.1999.0934","article-title":"Clinical outcome and its predictors in 1560 patients with critical leg ischaemia. Chronic Critical Leg Ischaemia Group","volume":"18","author":"Bertele","year":"1999","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","article-title":"Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery","volume":"43","author":"Conte","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib39","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.jvs.2008.07.062","article-title":"Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data","volume":"48","author":"Schanzer","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ccd.21974","article-title":"Clinical outcomes using aggressive approach to anatomic screening and endovascular revascularization in a veterans affairs population with critical limb ischemia","volume":"74","author":"Shah","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jvs.2007.11.055","article-title":"Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: implications for clinical trial design","volume":"47","author":"Rueda","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jvs.2007.09.018","article-title":"Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia","volume":"47","author":"DeRubertis","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib43","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jvs.2008.01.005","article-title":"Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia","volume":"47","author":"Romiti","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib44","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2016.02.007_bib45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejvs.2013.12.010","article-title":"Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis","volume":"47","author":"Biancari","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib46","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib47","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jvs.2014.11.045","article-title":"The society for vascular surgery lower extremity threatened limb classification system based on wound, ischemia, and foot infection (WIfI) correlates with risk of major amputation and time to wound healing","volume":"61","author":"Zhan","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib49","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1056\/NEJMcp1006054","article-title":"Clinical practice. Acute limb ischemia","volume":"366","author":"Creager","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib50","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jvs.2004.01.019","article-title":"National audit of thrombolysis for acute leg ischemia (NATALI): clinical factors associated with early outcome","volume":"39","author":"Earnshaw","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.sla.0000086663.49670.d1","article-title":"A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia","volume":"238","author":"Eliason","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib52","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCRESAHA.116.303503","article-title":"Endovascular intervention for peripheral artery disease","volume":"116","author":"Thukkani","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2016.02.007_bib53","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0741-5214(97)70053-3","article-title":"Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis","volume":"26","author":"de Vries","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib54","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jvs.2010.04.080","article-title":"A systematic review of endovascular treatment of extensive aortoiliac occlusive disease","volume":"52","author":"Jongkind","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib55","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.jvs.2011.02.005","article-title":"Early and late outcomes of percutaneous treatment of transatlantic inter-society consensus class C and D aorto-iliac lesions","volume":"53","author":"Ye","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2008.07.004","article-title":"The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction","volume":"48","author":"Kashyap","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jvs.2005.09.034","article-title":"Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients","volume":"43","author":"Leville","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib58","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jvs.2011.06.097","article-title":"A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease","volume":"54","author":"Mwipatayi","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib59","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jvir.2010.02.032","article-title":"Outcomes of covered kissing stent placement compared with bare metal stent placement in the treatment of atherosclerotic occlusive disease at the aortic bifurcation","volume":"21","author":"Sabri","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib60","first-page":"279","article-title":"Covered stents for aortoiliac reconstruction of chronic occlusive lesions","volume":"53","author":"Grimme","year":"2012","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.tcm.2016.02.007_bib61","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejvs.2008.06.027","article-title":"Kissing stents in the aortic bifurcation\u2014a valid reconstruction for aorto-iliac occlusive disease","volume":"36","author":"Bjorses","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib62","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1051-0443(97)70570-0","article-title":"Treatment of chronic iliac artery occlusions by means of percutaneous endovascular stent placement","volume":"8","author":"Dyet","year":"1997","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1583\/1074-6218(1998)005<0228:PETOIO>2.0.CO;2","article-title":"Percutaneous endoluminal treatment of iliac occlusions: long-term follow-up in 105 patients","volume":"5","author":"Henry","year":"1998","journal-title":"J Endovasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib64","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0002-9343(01)00727-6","article-title":"Stent-supported recanalization of chronic iliac artery occlusions","volume":"110","author":"Scheinert","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib65","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1148\/radiology.194.3.7862973","article-title":"Primary stent placement for chronic iliac artery occlusions: follow-up results in 103 patients","volume":"194","author":"Vorwerk","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.tcm.2016.02.007_bib66","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jvs.2008.05.025","article-title":"Common femoral artery occlusive disease: contemporary results following surgical endarterectomy","volume":"48","author":"Kang","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib67","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jacc.2011.01.070","article-title":"Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures","volume":"58","author":"Bonvini","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib68","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ccd.24475","article-title":"Acute and medium-term outcomes of endovascular therapy of obstructive disease of diverse etiology of the common femoral artery","volume":"81","author":"Dattilo","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib69","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ccd.21158","article-title":"Contemporary management of acute lower extremity ischemia following percutaneous coronary and cardiac interventional procedures using femoral access\u2014a case series and discussion","volume":"70","author":"Klein","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1118\/1.3006195","article-title":"In vivo 3D modeling of the femoropopliteal artery in human subjects based on x-ray angiography: methodology and validation","volume":"36","author":"Klein","year":"2009","journal-title":"Med Phys"},{"key":"10.1016\/j.tcm.2016.02.007_bib71","first-page":"193","article-title":"Treatment of superficial femoral artery occlusive disease","volume":"45","author":"Dorrucci","year":"2004","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.tcm.2016.02.007_bib72","first-page":"8","article-title":"Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease","volume":"10","author":"Gray","year":"1997","journal-title":"Semin Vasc Surg"},{"issue":"Suppl. 2","key":"10.1016\/j.tcm.2016.02.007_bib73","doi-asserted-by":"crossref","first-page":"II30","DOI":"10.1177\/15266028060130S107","article-title":"Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries","volume":"13","author":"Laird","year":"2006","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1583\/10-3248.1","article-title":"Outback catheter for femoropopliteal occlusions: immediate and long-term results","volume":"18","author":"Bausback","year":"2011","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1583\/11-3645.1","article-title":"Retrograde recanalization technique for use after failed antegrade angioplasty in chronic femoral artery occlusions","volume":"19","author":"Schmidt","year":"2012","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib76","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jvs.2010.03.050","article-title":"Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent","volume":"52","author":"Soga","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jcin.2014.10.016","article-title":"Outcomes of spot stenting versus long stenting after intentional subintimal approach for long chronic total occlusions of the femoropopliteal artery","volume":"8","author":"Hong","year":"2015","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib78","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.107.689141","article-title":"Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10cm in length: the femoral artery stenting trial (FAST)","volume":"116","author":"Krankenberg","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.02.007_bib79","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ccd.21104","article-title":"Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease","volume":"69","author":"Rocha-Singh","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib80","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib81","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jvs.2013.01.050","article-title":"Three-year results of the VIBRANT trial of VIABAHN endoprosthesis vs bare nitinol stent implantation for complex superficial femoral artery occlusive disease","volume":"58","author":"Geraghty","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib82","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jvir.2012.10.004","volume":"24","author":"Saxon","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib83","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2013.05.079","volume":"62","author":"Lammer","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib84","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jvs.2012.03.010","article-title":"Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease","volume":"56","author":"Johnston","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib85","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ccd.25666","article-title":"Above and below knee femoropopliteal VIABAHN(R)","volume":"85","author":"Shackles","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib86","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jvs.2014.12.062","article-title":"Safety and efficacy of antiplatelet\/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease","volume":"61","author":"Ullery","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib87","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib88","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib89","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/s00270-012-0543-5","article-title":"Drug-eluting nitinol stent treatment of the superficial femoral artery and above-the-knee popliteal artery (the Zilver PTX single-arm clinical study): a comparison between diabetic and nondiabetic patients","volume":"36","author":"Fanelli","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib90","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1024\/0301-1526\/a000170","article-title":"Drug-eluting stents for treatment of focal infrapopliteal lesions","volume":"41","author":"Rastan","year":"2012","journal-title":"Vasa"},{"key":"10.1016\/j.tcm.2016.02.007_bib91","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcin.2015.09.035","article-title":"Zilver PTX post-market surveillance study of paclitaxel-eluting stents for treating femoropopliteal artery disease in japan: 12-month results","volume":"Feb 8","author":"Yokoi","year":"2016","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib92","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jcin.2015.03.022","article-title":"1-year results of the ZEPHYR Registry (Zilver PTX for the femoral artery and proximal popliteal artery): predictors of restenosis","volume":"8","author":"Iida","year":"2015","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib93","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00270-012-0494-x","article-title":"A budget impact model for paclitaxel-eluting stent in femoropopliteal disease in France","volume":"36","author":"De Cock","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib94","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1148\/radiol.2402051248","article-title":"Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries","volume":"240","author":"Speck","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.tcm.2016.02.007_bib95","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib96","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib97","first-page":"207","article-title":"The DEBELLUM\u2014lower limb multilevel treatment with drug eluting balloon\u2014randomized trial: 1-year results","volume":"55","author":"Fanelli","year":"2014","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.tcm.2016.02.007_bib98","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib99","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.02.007_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Sustained Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","author":"Laird","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib102","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jcin.2013.07.010","article-title":"Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery)","volume":"6","author":"Liistro","year":"2013","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib103","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib104","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1583\/13-4630MR.1","article-title":"Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions","volume":"21","author":"Zeller","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/13-4420R.1","article-title":"Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study","volume":"21","author":"Liistro","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib106","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.jacc.2012.07.033","article-title":"Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis","volume":"60","author":"Stabile","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib107","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcin.2013.09.009","article-title":"Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study","volume":"7","author":"Werner","year":"2014","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib108","first-page":"231","article-title":"The value of subintimal angioplasty in the management of critical lower extremity ischemia: failure is not always associated with a rethreatened limb","volume":"45","author":"Lipsitz","year":"2004","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.tcm.2016.02.007_bib109","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCINTERVENTIONS.112.975318","article-title":"Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up","volume":"6","author":"Iida","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib110","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ccd.22658","article-title":"Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease","volume":"76","author":"Schmidt","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib111","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jacc.2011.05.034","article-title":"First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome","volume":"58","author":"Schmidt","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib112","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","article-title":"Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia","volume":"128","author":"Liistro","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.02.007_bib113","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib114","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jacc.2014.07.960","article-title":"Drug-coated balloons for infrapopliteal disease: digging deep to understand the impact of a negative trial","volume":"64","author":"Laird","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib115","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jacc.2009.11.072","article-title":"Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial","volume":"55","author":"Feiring","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib116","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial","volume":"60","author":"Rastan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib117","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jvs.2011.07.099","article-title":"Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease","volume":"55","author":"Bosiers","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib118","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2012.08.989","article-title":"A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial","volume":"60","author":"Scheinert","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib119","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jcin.2014.05.006","article-title":"Investigators DL. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study","volume":"7","author":"McKinsey","year":"2014","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib120","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1583\/13-4449MR.1","article-title":"Pooled analysis of the CONFIRM registries: safety outcomes in diabetic patients treated with orbital atherectomy for peripheral artery disease","volume":"21","author":"Lee","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib121","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ccd.21898","article-title":"Orbital atherectomy for infrapopliteal disease: device concept and outcome data for the OASIS trial","volume":"73","author":"Safian","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib122","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.carrev.2012.05.004","article-title":"Treatment of subacute and chronic thrombotic occlusions of lower extremity peripheral arteries with the excimer laser: a feasibility study","volume":"13","author":"Shammas","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib123","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1538574413478473","article-title":"Cool excimer laser-assisted angioplasty (CELA) and tibial balloon angioplasty (TBA) in management of infragenicular arterial occlusion in critical lower limb ischemia (CLI)","volume":"47","author":"Sultan","year":"2013","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib124","first-page":"655","article-title":"Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Diamantopoulos","year":"2014","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.tcm.2016.02.007_bib125","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0741-5214(94)70214-4","article-title":"A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia","volume":"19","author":"Ouriel","year":"1994","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib126","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199804163381603","article-title":"A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or peripheral arterial surgery (TOPAS) investigators","volume":"338","author":"Ouriel","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.02.007_bib127","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0741-5214(96)70067-8","article-title":"Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity","volume":"24","author":"Weaver","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1583\/05-1708.1","article-title":"Aortoiliac kissing stents: long-term results and analysis of risk factors affecting patency","volume":"13","author":"Yilmaz","year":"2006","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib129","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1253\/circj.CJ-12-0492","article-title":"Contemporary outcomes after endovascular treatment for aorto-iliac artery disease","volume":"76","author":"Soga","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.tcm.2016.02.007_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/11-3627.1","article-title":"Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial","volume":"19","author":"Laird","year":"2012","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib131","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib132","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2012.12.066","article-title":"The United States study for evaluating endovascular treatments of lesions in the superficial femoral artery and proximal popliteal by using the protege everflex nitinol stent system II (DURABILITY II)","volume":"58","author":"Matsumura","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib133","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ccd.25895","article-title":"A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial","volume":"86","author":"Rocha-Singh","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.02.007_bib134","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejvs.2012.07.015","article-title":"One-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions (the STELLA STEnting Long de L\u05f3Artere femorale superficielle cohort)","volume":"44","author":"Davaine","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.tcm.2016.02.007_bib135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1583\/11-3500.1","article-title":"A novel self-expanding interwoven nitinol stent for complex femoropopliteal lesions: 24-month results of the SUPERA SFA registry","volume":"18","author":"Scheinert","year":"2011","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib136","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1583\/13-4548R.1","article-title":"Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial","volume":"21","author":"Laird","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib137","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00270-014-1024-9","article-title":"Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial","volume":"38","author":"Lammer","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib138","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1583\/09-2781.1","article-title":"Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry","volume":"16","author":"Dave","year":"2009","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib139","first-page":"355","article-title":"The COMPLIANCE 360 degrees Trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease","volume":"26","author":"Dattilo","year":"2014","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/0003319711403300","article-title":"The 1-year clinical impact of rotational aspiration atherectomy of infrainguinal lesions","volume":"62","author":"Sixt","year":"2011","journal-title":"Angiology"},{"key":"10.1016\/j.tcm.2016.02.007_bib141","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.amjcard.2009.03.063","article-title":"Treatment of complex superficial femoral artery lesions with PolarCath cryoplasty","volume":"104","author":"Banerjee","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib142","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2012.05.042","article-title":"Pilot trial of cryoplasty or conventional balloon post-dilation of nitinol stents for revascularization of peripheral arterial segments: the COBRA trial","volume":"60","author":"Banerjee","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.02.007_bib143","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1583\/13-4308MR.1","article-title":"Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study","volume":"20","author":"Gandini","year":"2013","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.tcm.2016.02.007_bib144","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ccd.23475","article-title":"Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study","volume":"80","author":"Laird","year":"2012","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816000517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816000517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T19:16:25Z","timestamp":1718392585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173816000517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":144,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1050173816000517"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2016.02.007","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endovascular treatment of lower extremity peripheral arterial disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2016.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}